• OPEN AN ACCOUNT
Indian Indices
Nifty
24,968.40 -143.05
(-0.57%)
Sensex
81,757.73 -501.51
( -0.61%)
Bank Nifty
56,283.00 -545.80
( -0.96%)
Nifty IT
37,141.90 3.35
( 0.01%)
Global Indices
Nasdaq
44,363.41 142.09
(-0.32%)
Dow Jones
6,317.35 -1.01
(-0.02%)
Hang Seng
39,788.57 -112.62
(-0.28%)
Nikkei 225
8,992.12 19.48
(0.22%)
Forex
USD-INR
85.91 0.01
(0.01%)
EUR-INR
99.83 -0.21
(-0.21%)
GBP-INR
115.15 -0.11
(-0.09%)
JPY-INR
0.58 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Atmastco Ltd
Industry :  Engineering - Turnkey Services
BSE Code
ISIN Demat
Book Value()
74419
INE05DH01017
51.8359802
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ATMASTCO
31.06
617.75
EPS(TTM)
Face Value()
Div & Yield %
8.04
10
0
 

Bajaj Healthcare slides after WTD Dhananjay Sabaji Hatle resigns
Jun 06,2025

Bajaj Healthcare manufactures APIs and branded and generic formulations. It has five API manufacturing plants, located in Tarapur, Maharashtra, and Vadodara, Gujarat; one manufacturing plant of finished formulations in Vadodara, Gujarat; and one manufacturing plant of intermediates in Tarapur, Maharashtra.

Bajaj Healthcare reported standalone net profit of Rs 11.18 crore in Q4 FY25 as compared with net loss of Rs 29.92 crore posted in Q4 FY24. However, revenue from operations jumped 15.36% year-on-year (YoY) to Rs 154.47 crore in the quarter ended 31 March 2025.